volume 80, issue 1, P185-195 2021
DOI: 10.3233/jad-200946
View full text
Ellen Grober, Qi Qi, Lynn Kuo, Jason Hassenstab, Richard J. Perrin, Richard B. Lipton

Abstract: Background: The ultimate validation of a clinical marker for Alzheimer’s disease (AD) is its association with AD neuropathology. Objective: To examine how well the Stages of Objective Memory Impairment (SOMI) system predicts intermediate/high AD neuropathologic change and extent of neurofibrillary tangle (NFT) pathology defined by Braak stage, in comparison to the Clinical Dementia Rating (CDR) Scale sum of boxes (CDR-SB). Methods: 251 well-characterized participants from the Knight ADRC clinicopathologic seri…

expand abstract